… (CSC)-related markers has been confirmed in non-small cell lung cancer (NSCLC). The aim
of … markers in patients with NSCLC undergoing induction chemoradiotherapy (CRT). Fifty …

… survival in patients with locally advanced stage III non-small-cell lung cancer. We suggest
that surgery is a valid option in the treatment of stage IIIA non-small-cell lung cancer, and there …

… chemoradiotherapy (CCRT) in patients with locally advanced nonsmall cell lung cancer (…
published papers to quantitatively evaluate the potential benefit of induction chemotherapy. …

… may allow physicians to determine the optimal induction regimen for patients with IIIA (N2) …
if induction chemoradiotherapy is superior to induction chemotherapy alone in patients with …

… induction CT is a tolerable and cost effective treatment for non-small-cell lung cancer (NSCLC)
patients aged … between concurrent chemoradiotherapy (CCRT) and RT alone following …

… helpful for clinicians to determine the optimal induction treatment. We compared induction
chemoradiotherapy with induction chemotherapy from four aspects: tumor responses, pCR of …

… the induction chemoradiotherapy employed in this study was not appropriate for stage IIIB
patients, it proved feasible in stage IIIA patients … It also provided good survival rates in patients …

… In conclusion, induction chemotherapy followed by chemoradiation, such as that …
chemotherapy and operation after chemoradiation, especially in patients with tumors requiring …

… In Cancer and Leukemia Group B 39801, we evaluated whether induction chemotherapy
before concurrent chemoradiotherapy would result in improved survival. …

… Our results indicated that induction chemoradiotherapy was superior to induction chemotherapy
with regard to the outcome of non-small-cell lung cancer patients with mediastinal lymph …